Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00008437 · ClinicalTrials.gov registry record · Phase 2
MRI-Guided Ultrasound Energy in Treating Patients With Stage I, Stage II, or Stage IIIA Breast Cancer
A Phase 2 study, sponsored by InSightec.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00008437: Completed Phase 2 study, sponsored by InSightec.
NCT00008437 is a Phase 2 study that has completed, run by InSightec. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00008437, a Phase 2 study, has completed, sponsored by InSightec.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
RATIONALE: Imaging procedures, such as MRI, may allow the doctor to better detect the tumor. Highly focused ultrasound energy may be able to kill tumor cells by heating the breast tumor cells without affecting the surrounding tissue. PURPOSE: Phase II trial to study the effectiveness of MRI-guided ultrasound energy in treating women who have stage I, stage II, or stage IIIA breast cancer.
Interventions
- DEVICE high-intensity focused ultrasound ablation
Trial Details
| Field | Value |
|---|---|
| Start Date | 2000-12 |
| Est. Completion | 2000-12 |
| Phase | Phase 2 |
What the finished NCT00008437 record still lists
NCT00008437 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which high-intensity focused ultrasound ablation is the first listed.
NCT00008437 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00008437 about?
NCT00008437 is a clinical study titled "MRI-Guided Ultrasound Energy in Treating Patients With Stage I, Stage II, or Stage IIIA Breast Cancer". RATIONALE: Imaging procedures, such as MRI, may allow the doctor to better detect the tumor. Highly focused ultrasound energy may be able to kill tumor cells by heating the breast tumor cells without affecting the surrounding tissue. PURPOSE: Phase II trial to study the effectiveness of MRI-guided ...
What is the current status of trial NCT00008437?
This trial is currently completed. It is a Phase 2 study. The study started on 2000-12. Estimated completion is 2000-12.
What interventions are being tested in trial NCT00008437?
The interventions under investigation include: high-intensity focused ultrasound ablation (DEVICE).
Who is sponsoring clinical trial NCT00008437?
This trial is sponsored by InSightec, which has 38 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia